The global veterinary orthopedics market size was valued at USD 466.18 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.50% from 2023 to 2030. Growing pet adoption, pet expenditure, chronic diseases, number of veterinarians, and pet insurance is expected to accelerate the market growth. The 2020 PDSA Animal Wellbeing (PAW) Report stated that about 51% of U.K. citizens owned a pet. In addition, the report pegged U.K.’s dog and cat population at around 10.1 million and 10.9 million, respectively.
The COVID-19 pandemic led to a slowdown in the market due to movement restrictions, reduced veterinary visits, and delayed or canceled elective veterinary orthopedic surgeries. In March 2020, Harmony Veterinary Center in Colorado U.S. suspended all veterinary elective procedures, surgeries, and dentistry. According to the findings of an April 2020 survey by the American Veterinary Medical Association (AVMA), 98% of the respondent veterinary practitioners reported limiting client contact due to the outbreak while about two-thirds had deferred at least some surgical procedures.
The surgery volume across the globe recovered gradually as lockdown protocols were eased in several countries and many public health bodies released guidelines to support the resumption of veterinary surgeries. For instance, the Seven Hills Veterinary Hospital updated its protocols effective June 2021 and reported an increase in the volume of appointments/telephone calls/urgent care and emergency services including surgeries. Thus, although the COVID-19 pandemic led to a reduction in elective surgeries, the number is expected to bounce back in the coming years.
According to Banfield Pet Hospital’s 2020 report on Veterinary Emerging Topics, pet obesity in the U.S. has become an epidemic. Of the 1.9 million adult dogs examined at the hospital, 51% were reported to be overweight. Banfield Pet Hospital has observed this upward trend in pet obesity since 2007. The hospital reports that every 1 out of 3 cats and dogs were overweight. Obesity leads to comorbid conditions, such as osteoarthritis, which often require surgical interventions. For instance, as per Banfield Pet Hospital in 2017, arthritis/DJD, ligament/tendon conditions, and hip/pelvis conditions were the most common osteoarthritis conditions affecting dogs and cats. This led to an increase in orthopedic surgeries in canine pets.
According to the North American Pet Health Insurance Association (NAPHIA), there was a 21% increase in the pet health insurance sector in the region in 2019. NAPHIA reported continued growth in its sector even in 2020, despite some COVID-related challenges. All these factors are expected to continue fueling the regional growth over the forecast period. According to the 2019 Chinese Pet Industry report by Pet Fair Asia, urban Chinese were estimated to have spent about USD 28.8 billion on their pets (mainly cats and dogs). China’s pet insurance market, although in its early stages, is expected to grow significantly, thus making pet care and treatments affordable in the future. All these factors are anticipated to drive the Chinese market for veterinary orthopedics.
The TPLO segment dominated the market and accounted for a revenue share of over 20.0% in 2022. Tibial Plateau Leveling Osteotomy (TPLO) is a very popular method for repairing CCL rupture in dogs. It is recommended mainly for large-breed dogs but is also a good choice for moderate and small breeds. TPLO procedure enables a full return to an active lifestyle, which fuels its demand and thus the segment growth.
The American Veterinary Medical Association conducted a survey of members of the Veterinary Orthopedic Society (VOS) in 2016. As per its results, VOS members preferred the TPLO technique for treating CCL rupture in dogs weighing more than 15 kgs. The TTA segment is expected to grow at the fastest rate of 8.0% over the forecast period. This is due to the less-invasive TTA surgery compared to TPLO and other benefits. Other advantages that lead to the increased adoption of this surgical method are less postoperative pain, faster recovery compared to TPLO, and fewer complications.
The implants segment dominated the market in 2022 and projected to witness highest CAGR of over 7% over the forecast period. The implants segment is further segregated into plates, screws, and others. The plates segment comprises compression plates, arthrodesis plates, and acetabulum plates. According to scil animal care company, cruciate ligament repairs and traumas are the most common procedures that require veterinary orthopedic implants.
The instruments segment is expected to witness notable growth over the forecast period. According to veterinary surgeons, surgeries performed on small animals require extremely specialized surgical instruments that provide high precision and accuracy. These include bone cutting forceps, bone files, bone rasps, and more.
The hospitals and clinics segment dominated the market in 2022. Hospitals and clinics report the largest footfall and are better equipped to handle orthopedic procedures and surgeries. The availability of the necessary setup for diagnostic tests and post-surgical procedures makes this segment a preferred choice for pet parents and is expected to propel the market growth over the forecast period.
The others segment comprises veterinary research centers and ambulatory care units. It is anticipated to grow at the fastest CAGR 9.0% during the forecast period, which can be attributed to increasing R&D investments and funding for developing therapeutically advanced surgical techniques and implants.
North America dominated the market and accounted for a revenue share of more than 30.0% in 2022. According to 2018 findings of the Association for Pet Obesity Prevention, U.S., 59.5% of cats and 55.8% of dogs were categorized as obese, whereas in 2015, 58% of cats and 54% of dogs were identified to be obese. Obesity makes pets vulnerable to disorders such as hip and joint conditions, Cranial Cruciate Ligament (CCL) rupture, etc., which require surgery in severe cases. Other factors driving the North American market include the presence of major players and well-established healthcare infrastructure.
In Asia Pacific, the market is expected to register the fastest growth rate of 8.0% over the forecast period owing to factors such as the growing pet expenditure, humanization of pets, and the presence of market players. For instance, pets in Japan, especially cats and dogs, have a longer life expectancy, making them more susceptible to disorders of the knee/hip or elbow/shoulder associated with old age and trauma. This is expected to propel market growth.
The market is notably competitive. The market players are focused on increasing market share via various strategic initiatives including collaborations, distribution partnerships, mergers & acquisitions, and product development. The market is also witnessing consolidation. For instance, Vimian Group, based in Sweden, owns a family of companies including Movora (Animal MedTech), VetFamily (Veterinary Services), Indical Bioscience (Veterinary Diagnostics), and Nextmune (Veterinary Specialty Pharma).
Movora was created in 2020 with the acquisition of Kyon, BioMedtrix, and Veterinary Orthopedic Implants. It specializes in providing orthopedic implants to veterinarians and universities. Veterinary Orthopedic Implants was acquired in October 2019 whereas BioMedtrix, LLC was acquired in March 2020 and was made a part of Movora Company. Some prominent players in the global veterinary orthopedics market include
B. Braun Melsungen AG
Vimian: Movora
TruemedVet
Veterinary Instrumentation (Henry Schein)
Securos Surgical (AmerisourceBergen Corporation)
Orthomed (UK) Ltd
Arthrex, Inc.
Integra LifeSciences
GerVetUSA
DePuy Synthes VET
Report Attribute |
Details |
The market size value in 2023 |
USD 500.83 million |
The revenue forecast in 2030 |
USD 832.15 million |
Growth rate |
CAGR of 7.50% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2017 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million & CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Application, product, end use, region |
Regions covered |
North America; Europe; Asia Pacific; Latin America; MEA |
Country Scope |
U.S.; Canada; U.K.; Germany; Italy; France; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia |
Key companies profiled |
B. Braun Melsungen AG; Vimian: Movora; TruemedVet ; Veterinary Instrumentation (Henry Schein); Securos Surgical (AmerisourceBergen Corporation); Orthomed (UK) Ltd; Arthrex, Inc.; Integra LifeSciences; GerVetUSA; DePuy Synthes VET |
Customization scope |
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For this report, Grand View Research has segmented the global veterinary orthopedics market report based on application, product, end use, and region:
Application Outlook (Revenue, USD Million, 2017 - 2030)
Total Knee Replacement
Total Hip Replacement
Total Elbow Replacement
Trauma Fixation
TPLO
TTA
Lateral Fixation
Others
Product Outlook (Revenue, USD Million, 2017 - 2030)
Instruments
Implants
Plates
Compression Plates
Arthrodesis plates
Acetabulum plates
Screws
Others
End-use Outlook (Revenue, USD Million, 2017 - 2030)
Hospitals & Clinics
Others
Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
b. The global veterinary orthopedics market size was estimated at USD 466.18 million in 2022 and is expected to reach USD 500.83 million in 2023.
b. The global veterinary orthopedics market is expected to grow at a compound annual growth rate of 7.5% from 2023 to 2030 to reach USD 832.15 million by 2030.
b. Some key players operating in the veterinary orthopedics market include B. Braun Melsungen AG, Vimian: Movora; TruemedVet; Veterinary Instrumentation (Henry Schein); Securos Surgical; Orthomed (UK) Ltd; Arthrex Inc.; Integra Lifesciences; GerVet USA; and DePuy Synthes VET
b. North America dominated the veterinary orthopedics market with a share of over 30% in 2022. This is attributable to the presence of major players and well-established healthcare infrastructure.
b. Key factors that are driving the veterinary orthopedics market growth include growing pet adoption coupled with pet expenditure, chronic diseases, the number of veterinarians, and pet insurance.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
ESOMAR & Great Work to Place Certified
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."